Inari Medical Stock Net Asset
| NARIDelisted Stock | USD 79.97 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Inari Medical's long-term financial health and intrinsic value.
Inari |
Inari Medical Company Net Asset Analysis
Inari Medical's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Inari Medical Net Asset | 674.24 M |
Most of Inari Medical's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Inari Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
CompetitionBased on the recorded statements, Inari Medical has a Net Asset of 674.24 M. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
Inari Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Inari Medical's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Inari Medical could also be used in its relative valuation, which is a method of valuing Inari Medical by comparing valuation metrics of similar companies.Inari Medical is currently under evaluation in net asset category among its peers.
Inari Fundamentals
| Return On Equity | -0.18 | |||
| Return On Asset | -0.0321 | |||
| Profit Margin | (0.14) % | |||
| Operating Margin | (0.04) % | |||
| Current Valuation | 4.6 B | |||
| Shares Outstanding | 58.56 M | |||
| Shares Owned By Insiders | 8.99 % | |||
| Shares Owned By Institutions | 95.50 % | |||
| Number Of Shares Shorted | 2.48 M | |||
| Price To Earning | 275.35 X | |||
| Price To Book | 10.77 X | |||
| Price To Sales | 8.15 X | |||
| Revenue | 493.63 M | |||
| Gross Profit | 498.76 M | |||
| EBITDA | 15.19 M | |||
| Net Income | (1.64 M) | |||
| Cash And Equivalents | 330.5 M | |||
| Cash Per Share | 6.19 X | |||
| Total Debt | 32.05 M | |||
| Debt To Equity | 0.07 % | |||
| Current Ratio | 10.04 X | |||
| Book Value Per Share | 7.44 X | |||
| Cash Flow From Operations | 35.93 M | |||
| Short Ratio | 0.54 X | |||
| Earnings Per Share | (1.35) X | |||
| Price To Earnings To Growth | (1.88) X | |||
| Target Price | 78.03 | |||
| Number Of Employees | 1.3 K | |||
| Beta | 1.03 | |||
| Market Capitalization | 4.68 B | |||
| Total Asset | 674.24 M | |||
| Retained Earnings | (48.49 M) | |||
| Working Capital | 159.22 M | |||
| Net Asset | 674.24 M |
About Inari Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Inari Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inari Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inari Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| AMT | American Tower Corp | |
| HLTOY | Hellenic Telecommunications Org | |
| NFLX | Netflix | |
| EPGFX | Europac Gold Fund | |
| FTGFF | Firan Technology Group |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Inari Stock
If you are still planning to invest in Inari Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Inari Medical's history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |